Lymphoma-associated skin cancer: Incidence, natural history, and clinical management

International Journal of Dermatology

Volumn 53, Issue 3, 2014, Pages 267-274

  Brewer, Jerry D ^a   Habermann, Thomas M ^a   Shanafelt, Tait D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; HUMAN; IMMUNOLOGY; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; MELANOMA; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS;

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; MELANOMA; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS;

EID: 84894279773     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12208     Document Type: Review

References (66)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300. Erratum in: CA Cancer J Clin 2011; 61: 133-134.
2. Brewer JD, Colegio OR, Phillips PK, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145: 1391-1396.
3. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000; 7: 223-234.
4. Lanoy E, Costagliola D, Engels EA. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 2010; 126: 1724-1731.
5. Matin RN, Mesher D, Proby CM, et al. ; Skin Care in Organ Transplant Patients, Europe Group (SCOPE). Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8: 1891-1900.
6. Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995; 310: 1491-1495.
7. Greene MH, Hoover RN, Fraumeni JF Jr. Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunologic mechanism. J Natl Cancer Inst 1978; 61: 337-340.
8. Levi F, Randimbison L, Te VC, et al. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847-1850.
9. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975; 232: 267-269.
10. Agnew KL, Ruchlemer R, Catovsky D, et al. Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol 2004; 150: 1129-1135.
11. Ben-David A, Lazarov A, Lev S, et al. Merkel cell tumor and chronic lymphocytic leukemia: coincidence or a possible association? Dermatol Online J 2005; 11: 16.
12. Carroll P, Goldstein GD, Brown CW Jr. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg 2000; 26: 531-534.
13. Cottoni F, Masia IM, Cossu S, et al. Classical Kaposi's sarcoma and chronic lymphocytic leukaemia in the same skin biopsy: report of two cases. Br J Dermatol 1998; 139: 753-754.
14. Hull PR, Saxena A. Mycosis fungoides and chronic lymphocytic leukaemia: composite T-cell and B-cell lymphomas presenting in the skin. Br J Dermatol 2000; 143: 439-444.
15. Kemp JD, Stenn KS, Arons M, et al. Metastasizing atypical fibroxanthoma: coexistence with chronic lymphocytic leukemia. Arch Dermatol 1978; 114: 1533-1535.
16. Vergani R, Betti R, Uziel L, et al. Eruptive multiple sporadic cutaneous piloleiomyomas in a patient with chronic lymphocytic leukaemia. Br J Dermatol 2000; 143: 907-909.
17. Levine PH, Hoover R. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Cancer Epidemiol Biomarkers Prev 1992; 1: 515-517.
18. Adami J, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-645.
19. Clemente CG, Mihm MC Jr, Bufalino R, et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303-1310.
20. Aslakson CJ, Lee G, Boomer JS, et al. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. Am J Hematol 1999; 61: 46-52.
21. Ramsay AG, Johnson AJ, Lee AM, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest 2008; 118: 2427-2437.
22. Cantwell M, Hua T, Pappas J, et al. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med 1997; 3: 984-989.
23. Lacombe C, Gombert J, Dreyfus B, et al. Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia. Clin Immunol 1999; 90: 128-132.
24. Kipps TJ. Genetics of chronic lymphocytic leukaemia. Hematol Cell Ther 2000; 42: 5-14.
25. Brewer JD, Christenson LJ, Weenig RH, et al. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Dermatol Surg 2010; 36: 368-376.
26. McKenna DB, Doherty VR, McLaren KM, et al. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 2000; 143: 171-173.
27. Mehrany K, Weenig RH, Lee KK, et al. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 2005; 53: 1067-1071.
28. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004; 140: 985-988.
29. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 2005; 31: 38-42.
30. Brewer J, Shanafelt TD, Otley CC, et al. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol 2012; 30: 843-849.
31. Rashid K, Ng R, Mastan A, et al. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia. Leuk Lymphoma 2005; 46: 1051-1055.
32. Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma 2005; 46: 49-54.
33. Koljonen V, Kukko H, Pukkala E, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009; 101: 1444-1447.
34. Gandhi RK, Rosenberg AS, Somach SC. Merkel cell polyomavirus: an update. J Cutan Pathol 2009; 36: 1327-1329.
35. Dworkin AM, Tseng SY, Allain DC, et al. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009; 129: 2868-2874. Erratum in: J Invest Dermatol 2011; 131: 1388.
36. Otley CC. Non-Hodgkin lymphoma and skin cancer: a dangerous combination. Australas J Dermatol 2006; 47: 231-236.
37. Berg JW. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J Natl Cancer Inst 1967; 38: 741-752.
38. McKenna DB, Stockton D, Brewster DH, et al. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003; 88: 74-78.
39. Albregts T, Orengo I, Salasche S, et al. Squamous cell carcinoma in a patient with chronic lymphocytic leukemia: an intraoperative diagnostic challenge for the Mohs surgeon. Dermatol Surg 1998; 24: 269-272.
40. Karsai S, Hou JS, Telang G, et al. Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature. Dermatology 2008; 216: 68-75.
41. Konstantopoulos K, Kapsimalis V, Vaiopoulos G, et al. Simultaneous appearance of mycosis fungoides and chronic lymphocytic leukemia in the same patient. Haematologia (Budap) 2000; 30: 41-43.
42. Moayeri H, Han T, Stutzman L, et al. Second neoplasms with chronic lymphocytic leukemia. N Y State J Med 1976; 76: 378-381.
43. Pizarro A, Baron JM. Kaposi's sarcoma and lymphoid neoplasia in the same lesion. Arch Pathol Lab Med 1992; 116: 812-813.
44. Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904-910.
45. Liegl B, Leibl S, Okcu M, et al. Malignant transformation within benign adnexal skin tumours. Histopathology 2004; 45: 162-170.
46. Davidovitz Y, Ballin A, Meytes D. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Acta Haematol 1997; 98: 44-46.
47. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-778.
48. Mikhail GR. Metastatic basal cell carcinoma. J Dermatol Surg Oncol 1986; 12: 507-509.
49. Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003; 12: 1105-1108.
50. Miller PK, Roenigk RK, Brodland DG, et al. Cutaneous micrographic surgery: Mohs procedure. Mayo Clin Proc 1992; 67: 971-980.
51. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 2001; 76: 1253-1265.
52. Koh HK. Cutaneous melanoma. N Engl J Med 1991; 325: 171-182.
53. Coll-Mulet L, Gil J. Genetic alterations in chronic lymphocytic leukaemia. Clin Transl Oncol 2009; 11: 194-198.
54. Zenz T, Eichhorst B, Busch R, et al. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol 2010; 28: 4473-4479.
55. Khezri F, Brewer JD, Weaver AL. Merkel cell carcinoma in the setting of chronic lymphocytic leukemia. Dermatol Surg 2011; 37: 1100-1105.
56. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003; 29: 129-134.
57. Black HS, Herd JA, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med 1994; 330: 1272-1275.
58. Berwick M, Kesler D. Ultraviolet radiation exposure, vitamin D, and cancer. Photochem Photobiol 2005; 81: 1261-1266.
59. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004; 30: 656-661.
60. DiGiovanna JJ. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998; 39: S82-S85.
61. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007; 110: 1-12.
62. Shimm DS, Wilder RB. Radiation therapy for squamous cell carcinoma of the skin. Am J Clin Oncol 1991; 14: 383-386.
63. Gu YH, Du JX, Ma ML. Sirolimus and non-melanoma skin cancer prevention after kidney transplantation: a meta-analysis. Asian Pac J Cancer Prev 2012; 13: 4335-4339.
64. Smak Gregoor PJ. Sirolimus and skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367: 1565.
65. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004; 140: 75-79.
66. Lewis CM, Glisson BS, Feng L, et al. A phase II study of gefitnib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res 2012; 18: 1435-1446.